The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Analysis of the Lysosomal Lipid Metabolism Pathway and Other Pathways, Subgroups and Stages in Parkinson’s Disease
Study Rationale: Lysosomes are cellular compartments involved in clearing molecular debris. Several genes that work in the lysosome, including GBA1, GALC, SMPD1 and others, are known to be involved in...
-
2022: Accelerated Therapeutics Program, 2024(SUPPLEMENT) Small Molecule Mitochondrial Modulators for the Treatment of Parkinson's Disease
Study Rationale: Mitochondrial dysfunction is a crucial driver of the initiation and progression of Parkinson’s disease (PD). Mitochondria are structures that produce cellular energy, and in neurons...
-
Research Grant, 2023Construction of a Library of Digital Technologies for Use in Research and Care of Parkinson’s Disease
Study Rationale: The past decade has seen enormous growth in commercially available digital technologies — including sensors, devices and smartphone apps — for the detection and monitoring of...
-
Research Grant, 2024Powered Clothing and Wearable Robotics for Everyday Gait Support
Study Rationale: We’ve spent several years exploring the potential of supporting human movement with wearable robotics and we believe our work has tremendous potential for individuals with Parkinson’s...
-
Research Grant, 2023Chronos-PD: Using Proteomic Analysis to Detect Early Molecular Signatures of Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is a gradually progressive condition: by the time the disorder is recognized and diagnosed, it is often too late to protect or reverse the damage that has...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Analysis of Skin Biopsies from the Systemic Synuclein Sampling Study by Alpha-synuclein Seed Amplification Assay
Study Rationale: Alpha-synuclein seed amplification assays have been shown to enable an accurate and early diagnosis of Parkinson’s disease (PD). However, this test currently relies on cerebrospinal...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.